For following the competition: what moved in each program, several studies read as one move.
- BP-SCIG 20%
- IVIG-VImmune
- TAK-664
- + 1 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Primary Immunodeficiency Diseases to watchlistEvery Monday by email · turn it off any timePro · free during the beta